作者: &NA;,
期刊: Drugs in R & D (ADIS Available online 1999) 卷期: Volume 1, issue 4
页码: 341-342
ISSN:1174-5886
年代: 1999
出版商: ADIS
数据来源: ADIS
摘要:
&NA;Candoxatrilat (UK 73967) is a neutral endopeptidase inhibitor that is in phase I of development with Pfizer in the USA. Candoxatrilat is the active form of candoxatril. It is also in clinical trials for the treatment of renal failure.
点击下载: PDF (22KB)
返 回
版权所有 © 2009 NSTL国家科技图书文献中心
咨询热线:800-990-8900 010-58882057 Email:service@nstl.gov.cn
地址:北京市复兴路15号 100038 京ICP备05017586号